Actinogen pivotal Alzheimer’s disease trial demonstrates clinical benefit in older patients with mild to moderate disease, favorable safety profile and trends towards benefit in the overall populationGlobeNewswire Nov 19, 2026, 12:45:00 PM
Actinogen pivotal Alzheimer’s disease trial database lock milestone - topline results on track for mid-NovemberGlobeNewswire Oct 28, 2026, 12:51:20 PM
Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for NovemberGlobeNewswire Sep 23, 2026, 12:30:00 PM